Modi Ventures is a Houston-based early-stage venture capital firm investing at the intersection of technology and biology. The firm backs both funds and founders in the emerging bioeconomy, focusing on platforms that leverage AI, microfluidics, multiomics, precision medicine, synthetic biology, gene editing, and living therapies to positively impact human health. Modi Ventures takes a dual approach, investing in both direct startups and venture funds, which provides a unique perspective on capital trends and startup cycles within the tech-bio sector. The firm's portfolio includes companies developing cancer therapeutics, AI-driven diagnostics, and cell therapies, with recent participation in rounds such as Proxima's $80M seed in 2026.
Profile auto-generated from public sources — details unverified.